SLC5A2 and bacterial urinary tract infection: Therefore, she was considered a high-risk patient who developed a UTI because of dapagliflozin administration. When prescribing SGLT2 inhibitors to patients, clinicians should always consider the possibility of UTIs and cases in which the drugs should be used.